Tissue DonorsLiving DonorsKidney TransplantationTissue and Organ ProcurementDirected Tissue DonationGraft SurvivalCadaverTransplantation, HomologousHistocompatibility TestingHistocompatibilityGraft vs Host DiseaseGraft RejectionBone Marrow TransplantationImmunosuppressive AgentsUnrelated DonorsWaiting ListsHematopoietic Stem Cell TransplantationTransplantation ConditioningTreatment OutcomeAntilymphocyte SerumBlood DonorsWhole-Body IrradiationRetrospective StudiesTransplantsTime FactorsSurvival RateHeart TransplantationSurvival AnalysisTransplantationLung TransplantationRisk FactorsCyclosporineTacrolimusPostoperative ComplicationsImmunosuppressionCytomegalovirus InfectionsTransplantation ImmunologyFetal Tissue TransplantationMycophenolic AcidLiver FailureKidney Failure, ChronicImmunocompromised HostFollow-Up StudiesHLA AntigensBrain DeathHeart-Lung TransplantationTransplantation, AutologousTransplantation ToleranceTransplantation, HeterotopicBrain Tissue TransplantationTissue and Organ HarvestingBronchiolitis ObliteransIsoantibodiesRecurrenceCytomegalovirusHematologic NeoplasmsKidneyOpportunistic InfectionsBiopsyTransplantation, IsogeneicBK VirusProspective StudiesLiver DiseasesIslets of Langerhans TransplantationGanciclovirLiver TransplantationEnd Stage Liver DiseaseLymphoproliferative DisordersCreatinineAcute DiseaseCorneal TransplantationPrimary Graft DysfunctionPolyomavirus InfectionsIncidenceSkin TransplantationPostoperative PeriodKidney DiseasesStem Cell TransplantationT-LymphocytesLeukemiaCord Blood Stem Cell TransplantationDeathBlood Group IncompatibilityPatient SelectionCold IschemiaFatal OutcomeMycosesAntiviral AgentsCohort StudiesBlood TransfusionPrognosisRegistriesAnemia, AplasticTissue TransplantationInfectionSirolimusPolymerase Chain ReactionMice, Inbred C57BLRisk AssessmentKaplan-Meier Estimate